Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group

First Line Treatment ◽

Gemcitabine And Cisplatin

Panitumumab in combination with modified docetaxel/ cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group

Annals of Gastroenterology ◽

10.20524/aog.2018.0311 ◽

2018 ◽

Author(s):

Nikolaos Kentepozidis

Keyword(s):

Phase Ii ◽

Research Group ◽

Phase Ii Study ◽

Gastroesophageal Junction ◽

Line Treatment ◽

First Line ◽

Oncology Research ◽

Multicenter Phase ◽

Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2142-9 ◽

2013 ◽

Vol 71 (6) ◽

pp. 1445-1451 ◽

Cited By ~ 12

Author(s):

Young Hak Kim ◽

Masataka Hirabayashi ◽

Shinji Kosaka ◽

Junichi Nikaidoh ◽

Yasumichi Yamamoto ◽

...

Keyword(s):

Lung Cancer ◽

Research Group ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Oncology Research ◽

Group Trial ◽

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: A phase II study

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2005.06.013 ◽

2005 ◽

Vol 23 (5) ◽

pp. 381-382

Author(s):

Donald L. Trump

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

P47 Capecitabine, oxaliplatin and bevacizumab as first line treatment for elderly patients with metastatic colorectal cancer: a multicenter phase II trial from Hellenic Oncology Research Group

Critical Reviews in Oncology/Hematology ◽

10.1016/s1040-8428(09)70085-x ◽

2009 ◽

Vol 72 (1) ◽

pp. S35 ◽

Author(s):

L. Vamvakas ◽

A. Prinari ◽

A. Karampeazis ◽

N. Androulakis ◽

S. Giassas ◽

...

Keyword(s):

Colorectal Cancer ◽

Elderly Patients ◽

Metastatic Colorectal Cancer ◽

Research Group ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Oncology Research ◽

Multicenter Phase ◽

Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study

British Journal of Cancer ◽

10.1038/sj.bjc.6602378 ◽

2005 ◽

Vol 92 (4) ◽

pp. 645-650 ◽

Cited By ~ 50

Author(s):

A Ardavanis ◽

D Tryfonopoulos ◽

A Alexopoulos ◽

C Kandylis ◽

G Lainakis ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group

Clinical Breast Cancer ◽

10.1016/j.clbc.2017.10.013 ◽

2018 ◽

Vol 18 (1) ◽

pp. 88-94 ◽

Cited By ~ 7

Author(s):

Emmanouil Saloustros ◽

Michail Nikolaou ◽

Konstantinos Kalbakis ◽

Aris Polyzos ◽

Charalampos Christofillakis ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative Breast Cancer ◽

Research Group ◽

Triple Negative ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Oncology Research ◽

Multicenter Phase ◽

Final results of weekly paclitaxel and carboplatin plus bevacizumab as first-line treatment of triple-negative breast cancer. A multicenter phase I-II trial by the Hellenic Oncology Research Group

Annals of Oncology ◽

10.1093/annonc/mdw365.21 ◽

2016 ◽

Vol 27 ◽

pp. vi74 ◽

Author(s):

M. Nikolaou ◽

E. Saloustros ◽

A. Polyzos ◽

C. Christophyllakis ◽

N. Kentepozidis ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Triple Negative Breast Cancer ◽

Research Group ◽

Triple Negative ◽

Line Treatment ◽

First Line ◽

Oncology Research ◽

Multicenter Phase ◽

SUCCINCT: An Open-label, Single-arm, Non-randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-line Treatment for Patients with Advanced Urothelial Carcinoma

European Urology ◽

10.1016/j.eururo.2014.11.003 ◽

2015 ◽

Vol 67 (4) ◽

pp. 599-602 ◽

Cited By ~ 23

Author(s):

Thomas Geldart ◽

John Chester ◽

Angela Casbard ◽

Simon Crabb ◽

Tony Elliott ◽

...

Keyword(s):

Urothelial Carcinoma ◽

Line Treatment ◽

Phase 2 ◽

First Line ◽

Open Label ◽

Phase 2 Trial ◽

First Line Treatment ◽

Gemcitabine And Cisplatin

Re: SUCCINCT: An Open-Label, Single-Arm, Non-Randomised, Phase 2 Trial of Gemcitabine and Cisplatin Chemotherapy in Combination with Sunitinib as First-Line Treatment for Patients with Advanced Urothelial Carcinoma

The Journal of Urology ◽

10.1016/j.juro.2015.09.005 ◽

2015 ◽

Vol 194 (6) ◽

pp. 1583-1585 ◽

Author(s):

Sam S. Chang

Keyword(s):

Urothelial Carcinoma ◽

Line Treatment ◽

Phase 2 ◽

First Line ◽

Open Label ◽

Phase 2 Trial ◽

First Line Treatment ◽

Gemcitabine And Cisplatin

A multicenter phase II study of epirubicin with low-dose trastuzumab as a first line treatment in Her-2 overexpressing metastatic breast cancer: preliminary results

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)80420-9 ◽

2006 ◽

Vol 4 (2) ◽

pp. 165

Author(s):

M. Zilli ◽

De Tursi ◽

C. Carella ◽

E. Ricevuto ◽

P. Marchetti ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Low Dose ◽

Phase Ii Study ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Multicenter Phase ◽

Her 2 ◽